Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.19.1
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Feb. 28, 2019
Feb. 28, 2018
Cash flows from operating activities:    
Net income (loss) $ 275,877 $ (2,530,072)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 104,870 60,278
Change in fair value of contingent consideration 367,057  
Compensatory element of stock options 138,982 555,595
Provision for doubtful accounts 240,643 69,432
Deferred income tax expense   3,047,332
Amortization of debt issuance costs 29,894 26,702
Changes in assets and liabilities:    
Accounts receivable (67,470) 128,408
Prepaid expenses 1,261 74,052
Inventory (96,712) (59,876)
Other current assets 49,570 (7,681)
Deposits and other assets, net 68,250  
Accounts payable (251,261) (730,624)
Accrued expenses 217,220 282,972
Deferred revenue 708,682 775,345
Net provided by operating activities 1,786,863 1,691,863
Cash flows used in investing activities:    
Purchases of property and equipment (49,085) (253,704)
Purchase of intangible asset   (200,000)
Sales (purchases) of marketable securities and other investments, net 67,179 (28,162)
Net cash provided by (used in) investing activities 18,094 (481,866)
Cash flows from financing activities:    
Repayments of note payable (774,999) (500,000)
Proceeds from the exercise of stock options 5,700 2,250
Net cash used in financing activities (769,299) (497,750)
Increase in cash and cash equivalents 1,035,658 712,247
Cash and cash equivalents - beginning of period 6,040,033 6,279,154
Cash and cash equivalents - end of period 7,075,691 6,991,401
Supplemental non-cash investing activities:    
Unrealized gain on marketable securities, net of tax   $ 118,746
Cumulative-effect adjustment due to the adoption of ASU 2016-01 $ (340,984)